Wellington Management Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

Wellington Management Group’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-161,145	Closed	-$6.39M	–	1999
2024 Q1	$6.39M	Buy	161,145 +51,263	+47%	+$1.51M	﹤0.01%	1271
2023 Q4	$2.09M	Buy	109,882 +70,151	+177%	+$975K	﹤0.01%	1487
2023 Q3	$455K	Buy	+39,731	New	+$489K	﹤0.01%	1710
2017 Q1	–	Sell	-318,064	Closed	-$2.85M	–	2327
2016 Q4	$2.85M	Sell	318,064 -62,808	-16%	-$1.25M	﹤0.01%	1586
2016 Q3	$12.4M	Sell	380,872 -2,034	-0.5%	-$49.5K	﹤0.01%	1112
2016 Q2	$7.04M	Sell	382,906 -54,551	-12%	-$968K	﹤0.01%	1242
2016 Q1	$7.3M	Sell	437,457 -15,406	-3%	-$308K	﹤0.01%	1246
2015 Q4	$14M	Sell	452,863 -87,951	-16%	-$3M	﹤0.01%	1073
2015 Q3	$28.1M	Buy	540,814 +129,139	+31%	+$8.48M	0.01%	859
2015 Q2	$24.6M	Buy	+411,675	New	+$24.5M	0.01%	949

Wellington Management Group's ALPN Position: Q2 2024 in Review

Wellington Management Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 161,145 shares — an estimated $6.39M sold.

Wellington Management Group first reported a position in ALPN in Q2 2015 and held it in 10 quarters. The position peaked at $28.1M in Q3 2015. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Wellington Management Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Wellington Management Group sold 161,145 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $6.39M.
Wellington Management Group first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 10 quarters.
Wellington Management Group's Alpine Immune Sciences Inc position peaked at $28.1M in Q3 2015.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.